中国肺癌杂志2016，Vol.19Issue(1)：24-29,6.DOI:10.3779/j.issn.1009-3419.2016.01.03
TRIM24介导肺癌细胞吉非替尼耐药机制探讨
Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
摘要
关键词
肺肿瘤/吉非替尼/表皮生长因子受体酪氨酸激酶抑制剂Key words
Lung neoplasms/Gefitinib/Epidermal growth factor receptor tyrosine kinase inhibitor引用本文复制引用
李海英,王庆苓,包海军,张恒,庄莹..TRIM24介导肺癌细胞吉非替尼耐药机制探讨[J].中国肺癌杂志,2016,19(1):24-29,6.基金项目
This study was supported by grants from National Natural Science Foundation of China (to Qingling WANG) (No.81101493),National Natural Science Foundation of China (to Haijun BAO) (No.81302612) and Specialized Research Fund for Doctor of Xuzhou Medical College (to Haiying LI) (No.D2014003).本研究受国家自然科学基金项目(No.81101493)、国家自然科学基金项目(No.81302612)和徐州医学院人才项目启动基金(No.D2014003)资助 （to Qingling WANG）
